{"id":839872,"date":[{"year":1991,"month":5,"day":27}],"page":"2","source":"本报","region":"","masthead":"综合新闻","special_issue":"","column":"","genre":"","count":"253","ytitle":"","mtitle":"急、慢性乙肝有了“克星”","ftitle":"","authors":["志铨"],"text":[{"type":"paragraph","text":"本报讯　急慢性乙型肝炎有了强有力的“克星”——“灭澳灵”。这种被列为解放军总后勤部重点科研项目、由吉林省长春东宝制药厂生产的药品日前在沪推广应用大受欢迎。"},{"type":"paragraph","text":"四年来全国已有150万患者临床应用“灭澳灵”，对治疗急、慢性乙型肝炎有显著疗效。临床跟踪验证，它治疗急性乙型肝炎治愈率为92.2%，表面抗原转阴率50%；慢性乙型肝炎治愈率为64.5%，表面抗原转阴率45.5%。"},{"type":"paragraph","text":"这个科研项目曾获全军医药科技进步二等奖，1988年获第16届南斯拉夫萨格勒布国际发明展览会荣誉奖。　(志铨)"}]}